ID28460A - COMPOSITION AND METHODS FOR TREATMENT AND PREVENTION OF BONE DISEASE USING TOCOTRIENOL - Google Patents

COMPOSITION AND METHODS FOR TREATMENT AND PREVENTION OF BONE DISEASE USING TOCOTRIENOL

Info

Publication number
ID28460A
ID28460A IDW20010301A ID20010301A ID28460A ID 28460 A ID28460 A ID 28460A ID W20010301 A IDW20010301 A ID W20010301A ID 20010301 A ID20010301 A ID 20010301A ID 28460 A ID28460 A ID 28460A
Authority
ID
Indonesia
Prior art keywords
tocotrienol
prevention
treatment
composition
methods
Prior art date
Application number
IDW20010301A
Other languages
Indonesian (id)
Inventor
Ronald H Lane
Original Assignee
Lipogenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogenics Inc filed Critical Lipogenics Inc
Publication of ID28460A publication Critical patent/ID28460A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW20010301A 1998-07-08 1999-07-06 COMPOSITION AND METHODS FOR TREATMENT AND PREVENTION OF BONE DISEASE USING TOCOTRIENOL ID28460A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9210198P 1998-07-08 1998-07-08

Publications (1)

Publication Number Publication Date
ID28460A true ID28460A (en) 2001-05-24

Family

ID=22231570

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010301A ID28460A (en) 1998-07-08 1999-07-06 COMPOSITION AND METHODS FOR TREATMENT AND PREVENTION OF BONE DISEASE USING TOCOTRIENOL

Country Status (6)

Country Link
EP (1) EP1109548A4 (en)
JP (1) JP2002520280A (en)
CN (1) CN1316903A (en)
AU (1) AU4732499A (en)
ID (1) ID28460A (en)
WO (1) WO2000002553A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
AU2001232182A1 (en) * 2001-01-15 2002-07-24 Kgk Synergize Compositions and methods for regulating lipoproteins and hypercholesterolmia with limonoids flavonoids and tocotrienols
PL370080A1 (en) * 2001-10-10 2005-05-16 Pharmacia Italia Spa Methods for preventing and treating bone loss with steroid compounds
WO2003092666A1 (en) * 2002-05-01 2003-11-13 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Calcium-containing tissue strengthening agents and use thereof
FR2841472B1 (en) * 2002-06-28 2006-02-24 Agronomique Inst Nat Rech NUTRITIONAL OR THERAPEUTIC COMPOSITION CONTAINING THE HESPERIDINE COMPOUND OR ONE OF ITS DERIVATIVES
FR2899106B1 (en) * 2002-11-19 2015-04-24 Engelhard Lyon USE OF A SUBSTANCE TO LIMIT AND / OR PREVENT THE MODIFICATION OF AT LEAST ONE MODIFIED BIOLOGICAL PARAMETER DURING IRRADIATION
AR045799A1 (en) * 2003-09-24 2005-11-16 Glaxo Group Ltd COMPOUND 6- OXO-2,5- DIOXABICICLIC AND ITS USE TO PREPARE A PHARMACEUTICAL COMPOSITION
WO2006024096A1 (en) * 2004-08-31 2006-03-09 Chemgenex Pharmaceuticals Limited Method for modulating osteoclastogenesis
WO2006039336A2 (en) * 2004-10-01 2006-04-13 Ramscor, Inc. Conveniently implantable sustained release drug compositions
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
AU2005322015B2 (en) 2004-12-29 2010-02-25 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
JP5284087B2 (en) 2005-07-14 2013-09-11 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド Ways to prolong animal life
US8288369B2 (en) * 2006-06-27 2012-10-16 University Of South Florida Delta-tocotrienol treatment and prevention of pancreatic cancer
JP5337405B2 (en) 2007-09-17 2013-11-06 ザ・ホスピタル・フォー・シック・チルドレン How to treat Gaucher disease
AU2016200420B2 (en) * 2008-12-30 2017-03-02 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
WO2010104079A1 (en) * 2009-03-13 2010-09-16 明治乳業株式会社 Composition for reducing bone fracture risk and/or preventing bone fracture
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
EP3024328A4 (en) * 2013-07-22 2017-06-21 Ohio State Innovation Foundation Methods for reducing the occurrence of hot flashes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0645533B2 (en) * 1985-02-09 1994-06-15 ライオン株式会社 Cosmetics
US5574063A (en) * 1989-10-12 1996-11-12 Perricone; Nicholas V. Method and compositions for topical application of ascorbic acid fatty acid esters for treatment and/or prevention of skin damage

Also Published As

Publication number Publication date
CN1316903A (en) 2001-10-10
JP2002520280A (en) 2002-07-09
AU4732499A (en) 2000-02-01
EP1109548A1 (en) 2001-06-27
EP1109548A4 (en) 2001-12-12
WO2000002553A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
ID28460A (en) COMPOSITION AND METHODS FOR TREATMENT AND PREVENTION OF BONE DISEASE USING TOCOTRIENOL
CY2018020I1 (en) TREATMENT OF ROMRE'S DISEASE
EP1416961A4 (en) Composition and method for the treatment of disease
ID25504A (en) PREVENTION AND TREATMENT OF AMILOIDOGENIC DISEASE
DE69836752D1 (en) PROSTAGLAND INAGONIST AND ITS USE FOR THE TREATMENT OF BONE DISEASES
DE69924574D1 (en) Components and tools for intramedullary revision surgery of the tibia
ID21332A (en) METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF HYPERURICEMIA
DE60023128D1 (en) PYRAZOLECARBOXAMIDE FOR THE TREATMENT OF FATIBILITY AND OTHER DISEASES
ID30062A (en) SUBSTITUTIONAL BENZOPIRAN ANALOGUE FOR TREATMENT OF RADANG
HUP0103255A3 (en) Compositions and methods for treatment of mitochondrial diseases
DE69836915D1 (en) MOUTHPROOF TREATMENT FOR TREATMENT OF SMOKING ATEM
EP1021177A4 (en) Compositions and methods for prevention and treatment of vascular degenerative diseases
DE69926385D1 (en) TREATMENT OF TISSUE
DE69836008D1 (en) COMPOSITION AND TREATMENT AGENT
DE69806801D1 (en) GALENIC PREPARATION FOR THE PREVENTION AND TREATMENT OF HEPATOCARCINOMA
EE9800234A (en) Method of treatment and pharmaceutical composition
DE69812784D1 (en) Composition for the prevention and elimination of plant diseases
ID29547A (en) METHODS AND COMPOSITIONS FOR TUBERCULOSIS PREVENTION AND TREATMENT
DE69620691D1 (en) Therapeutic agent for the treatment of hypercholesterolemia
ID28894A (en) METHODS AND COMPOSITION FOR TREATMENT OF GASTRO-ESOPHAGEAL DISEASES
DE69825319D1 (en) PREPARATION FOR THE PREVENTION AND TREATMENT OF INFLAMMATION
DE69905214D1 (en) Agents for the treatment of osteoporosis
NO20012106D0 (en) Drug for the treatment of bone pathobolism
ATE314064T1 (en) L-ACETYLCARNITINE AND L-PROPIONYLCARNITINE COMPOSITION FOR THE PREVENTION AND TREATMENT OF KIDNEY DISORDERS AND KIDNEY DISEASE
GB0127618D0 (en) "Composition and method for treatment of wounds"